David H. Raulet - Concepedia

Author

David H. Raulet

University of California, Berkeley ORCID

Also Known As

D H Raulet, D Raulet, D. H. Raulet, D. Raulet, D.H. Raulet, DAVID H. RAULET, DH Raulet, David H Raulet, David H. Raulet, David Raulet

311

Publications

39.6K

Citations

H-Index

148

Concepts

All Affiliations

University of California, Berkeley Massachusetts Institute of Technology Center for Cancer Research

About

David H. Raulet is an author at University of California, Berkeley specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	61	97	20.2K
2	Natural Sciences	7	7	771
3	Engineering	3	3	132
4	Health Sciences	3	3	1.4K
5	Education	1	1	40

David H. Raulet

161

Publications

27.2K

Citations

H-Index

Page 1

	Year	Citations
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Fiona Harding, James G. McArthur, Jane A. Gross, Nature Autoimmune DiseaseT-cell ClonesImmunologyPrevents InductionAutoimmunity	1992	1.5K
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor Stephan Gasser, Sandra Oršulić, Eric J. Brown, Nature Nkg2d ReceptorImmune System LigandsAutoimmune DiseaseDna Damage PathwayAdaptive Immune System	2005	1.3K
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Andreas Diefenbach, Eric R. Jensen, A. M. Jamieson, Nature Cancer ImmunosurveillanceH60 LigandsImmunologyTumor ImmunityImmunologic Mechanism	2001	1.1K
Developmental potential and dynamic behavior of hematopoietic stem cells Ihor R. Lemischka, David H. Raulet, Richard C. Mulligan Cell Developmental BiologyDynamic BehaviorMedicineStem Cell MobilizationAdult Stem Cell	1986	879
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages Andreas Diefenbach, A. M. Jamieson, Scot D. Liu, Nature Immunology Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityImmunologic Mechanism	2000	860
Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease Bertrand Meresse, Zhangguo Chen, Cezary Ciszewski, Immunity InflammationAutoimmune DiseaseCeliac DiseaseT-regulatory CellImmunology	2004	825
NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy Nadia Guerra, Ying Xim Tan, Nathalie T. Joncker, Immunity Cancer ImmunosurveillanceSpontaneous MalignancyMedicineImmunologyTumor Immunity	2008	806
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, Journal of Clinical Investigation ImmunologyNk CellsImmunologic MechanismImmune Cell TherapyImmunotherapy	2018	796
The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing A. M. Jamieson, Andreas Diefenbach, Christopher W. McMahon, Immunity InflammationNatural Killer CellsAutoimmune DiseaseNatural KillingImmunology	2002	627
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response Assaf Marcus, Amy J. Mao, Monisha Lensink-Vasan, Immunity Cancer ImmunosurveillanceImmunologyTumor ImmunityImmunologic MechanismImmune Surveillance	2018	582

Page 1